MedTrace Logo

Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement

NCT06802068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-02-23

No results posted yet for this study

Summary

Omega-3 index is used as a proxy for an adequate intake of fish unsaturated fats in the diet. However, omega-3 supplements have not consistently shown the health benefits of eating fresh fish. This study will assess the change in omega-3 index and impact on markers of cardiometabolic health with two different supplements: a whole, unprocessed salmon oil and a standard, processed, concentrated oemga-3 oil. The markers to be studies included impact on inflammation and oxidative stress, cholesterol and markers of risk of diabetes. Change in sleep metrics will also be assessed.

Conditions

  • Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health

Interventions

DIETARY_SUPPLEMENT

whole salmon oil

A minimally processed whole salmon oil

DIETARY_SUPPLEMENT

Cod liver oil

Standard, processed omega-3 cod liver oil

Sponsors & Collaborators

  • Hofseth Biocare ASA

    lead INDUSTRY

Principal Investigators

  • Crawford Currie, MBBS · HBC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-18
Primary Completion
2025-12-23
Completion
2026-01-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802068 on ClinicalTrials.gov